What type of study is this?

This is a Pre-Registered Trial study.

December 8, 2025Blood

Update AML: Updated disease monitoring and treatment to enhance outcomes for pediatric AML (NCT07059975)

View Full Paper

Ask AI

Bookmark

Two intensified chemotherapy cycles improved treatment tolerance in pediatric acute myeloid leukemia patients, and showed promising effects.
The pilot study observed significant improvements in toxicity management and monitoring biomarkers throughout the trial.
Using the innovative agent venetoclax, significant changes in cellular response were monitored for high-risk groups before stem cell transplantation.
Study results may inform future protocols for testing and monitoring pediatric acute myeloid leukemia treatments and care strategies.

No takes yet. Share an insight, caveat, or question.

Pilot study tests new therapy regimens in pediatric AML patients, indicating potential for better quality of life and survival rates.

Stevens et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark